451 related articles for article (PubMed ID: 10451781)
1. Pharmacokinetics of opioids in liver disease.
Tegeder I; Lötsch J; Geisslinger G
Clin Pharmacokinet; 1999 Jul; 37(1):17-40. PubMed ID: 10451781
[TBL] [Abstract][Full Text] [Related]
2. [Therapy with opioids in liver or renal failure].
Tegeder I; Geisslinger G; Lötsch J
Schmerz; 1999 Jun; 13(3):183-95. PubMed ID: 12799931
[TBL] [Abstract][Full Text] [Related]
3. Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J
Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of opioids in renal dysfunction.
Davies G; Kingswood C; Street M
Clin Pharmacokinet; 1996 Dec; 31(6):410-22. PubMed ID: 8968655
[TBL] [Abstract][Full Text] [Related]
5. Enhanced bioavailability of pethidine and pentazocine in patients with cirrhosis of the liver.
Pond SM; Tong T; Benowitz NL; Jacob P
Aust N Z J Med; 1980 Oct; 10(5):515-9. PubMed ID: 6937164
[TBL] [Abstract][Full Text] [Related]
6. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease.
Murphy EJ
Anaesth Intensive Care; 2005 Jun; 33(3):311-22. PubMed ID: 15973913
[TBL] [Abstract][Full Text] [Related]
7. Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis.
Neal EA; Meffin PJ; Gregory PB; Blaschke TF
Gastroenterology; 1979 Jul; 77(1):96-102. PubMed ID: 447033
[TBL] [Abstract][Full Text] [Related]
8. First-pass elimination. Basic concepts and clinical consequences.
Pond SM; Tozer TN
Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
[TBL] [Abstract][Full Text] [Related]
9. "Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine.
Prescrire Int; 2016 Feb; 25(168):45-50. PubMed ID: 27042732
[TBL] [Abstract][Full Text] [Related]
10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of pethidine.
Mather LE; Meffin PJ
Clin Pharmacokinet; 1978; 3(5):352-68. PubMed ID: 359212
[TBL] [Abstract][Full Text] [Related]
12. Development of a new multi-analyte assay for the simultaneous detection of opioids in serum and other body fluids using liquid chromatography-tandem mass spectrometry.
Eckart K; Röhrich J; Breitmeier D; Ferner M; Laufenberg-Feldmann R; Urban R
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():1-8. PubMed ID: 26241181
[TBL] [Abstract][Full Text] [Related]
13. Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine.
Hajda JP; Jähnchen E; Oie S; Trenk D
J Clin Pharmacol; 2002 Nov; 42(11):1257-61. PubMed ID: 12412825
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the pattern of opioid analgesic consumption in Spain].
Carvajal A; García del Pozo J; Martín Arias LH; Martín de Diego I; Rueda AM; Caro-Patón T; Alvarez Requejo A
Med Clin (Barc); 1997 Sep; 109(8):281-3. PubMed ID: 9379748
[TBL] [Abstract][Full Text] [Related]
15. Disposition of pethidine in man under acidic urinary PH. I. Plasma level and urinary elimination of pethidine and norpethidine.
Chan K
J Clin Hosp Pharm; 1981 Jun; 6(2):107-16. PubMed ID: 7343560
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts.
Girardin F; Rentsch KM; Schwab MA; Maggiorini M; Pauli-Magnus C; Kullak-Ublick GA; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2003 Oct; 74(4):341-52. PubMed ID: 14534521
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of tilidine and naloxone in patients with severe hepatic impairment.
Brennscheidt U; Brunnmüller U; Proppe D; Thomann P; Seiler KU
Arzneimittelforschung; 2007; 57(2):106-11. PubMed ID: 17396621
[TBL] [Abstract][Full Text] [Related]
18. Effects of renal insufficiency on the pharmacokinetics and pharmacodynamics of opioid analgesics.
Chan GL; Matzke GR
Drug Intell Clin Pharm; 1987 Oct; 21(10):773-83. PubMed ID: 3322755
[TBL] [Abstract][Full Text] [Related]
19. Factors and conditions affecting the glucuronidation of oxazepam.
Sonne J
Pharmacol Toxicol; 1993; 73 Suppl 1():1-23. PubMed ID: 8415417
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. a minireview.
Ing Lorenzini K; Daali Y; Dayer P; Desmeules J
Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):219-26. PubMed ID: 21995512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
